Cargando…
Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I–IV...
Autores principales: | Erra, Elina O., Askling, Helena Hervius, Yoksan, Sutee, Rombo, Lars, Riutta, Jukka, Vene, Sirkka, Lindquist, Lars, Vapalahti, Olli, Kantele, Anu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526254/ https://www.ncbi.nlm.nih.gov/pubmed/23074319 http://dx.doi.org/10.1093/cid/cis883 |
Ejemplares similares
-
A Single Dose of Vero Cell–Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain–Derived JE Vaccines
por: Erra, Elina O., et al.
Publicado: (2012) -
Neuropsychiatric Sequelae of Japanese encephalitis (JE)
por: Singhai, Samiksha, et al.
Publicado: (2022) -
Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization
por: Feroldi, Emmanuel, et al.
Publicado: (2017) -
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014) -
Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)